Treating hepatitis C: Are children the same as adults?

Gastroenterology

Volumn 140, Issue 2, 2011, Pages 389-392

  Delgadoborrego, Aymin ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; INTERLEUKIN 28B; PEGINTERFERON; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; PLACEBO; RECOMBINANT ALPHA INTERFERON; RIBAVIRIN; VIRUS RNA;

ABDOMINAL PAIN; AFRICAN AMERICAN; ALOPECIA; ANEMIA; ANOREXIA; ANTIVIRAL THERAPY; APPETITE; ARTHRALGIA; BEHAVIOR DISORDER; CHILDHOOD DISEASE; DEPRESSION; DERMATITIS; DIZZINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; FATIGUE; FLU LIKE SYNDROME; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPOTHYROIDISM; INJECTION SITE ERYTHEMA; INJECTION SITE REACTION; IRRITABILITY; LETHARGY; LEUKOPENIA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; MONOTHERAPY; MOOD CHANGE; MYALGIA; NAUSEA; NEUTROPENIA; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIDE EFFECT; TREATMENT DURATION; TREATMENT RESPONSE; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION; VOMITING; WEIGHT REDUCTION;

EID: 79251573247     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.12.017     Document Type: Editorial

References (30)

1. S. Zeuzem Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well? Ann Intern Med 140 2004 370 381
2. A.R. El-Zayadi Hepatitis C comorbidities affecting the course and response to therapy World J Gastroenterol 15 2009 4993 4999
3. A.K. Singal, and B.S. Anand Management of hepatitis C virus infection in HIV/HCV co-infected patients: clinical review World J Gastroenterol 15 2009 3713 3724
4. M. Romero-Gomez, M. Del Mar Viloria, and R.J. Andrade Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients Gastroenterology 128 2005 636 641
5. D. Ge, J. Fellay, and A.J. Thompson Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature 461 2009 399 401
6. Mitchell AE, Colvin HM, Palmer Beasley R. Institute of Medicine recommendations for the prevention and control of hepatitis B and C. Hepatology;51:729733.
7. M. Ruiz-Moreno, M.J. Rua, and I. Castillo Treatment of children with chronic hepatitis C with recombinant interferon-alpha: a pilot study Hepatology 16 1992 882 885
8. F. Bortolotti, R. Giacchino, and P. Vajro Recombinant interferon-alfa therapy in children with chronic hepatitis C Hepatology 22 1995 1623 1627
9. M.M. Jonas, M.J. Ott, and S.P. Nelson Interferon-alpha treatment of chronic hepatitis C virus infection in children Pediatr Infect Dis J 17 1998 241 246
10. S. Wirth, T. Lang, and S. Gehring Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C Hepatology 36 2002 1280 1284
11. R.P. Gonzalez-Peralta, D.A. Kelly, and B. Haber Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics Hepatology 42 2005 1010 1018
12. S. Wirth, C. Ribes-Koninckx, and M.A. Calzado High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin J Hepatol 52 2010 501 507
13. V.H. Ferm, C. Willhite, and L. Kilham Teratogenic effects of ribavirin on hamster and rat embryos Teratology 17 1978 93 101
14. D.M. Kochhar, J.D. Penner, and T.B. Knudsen Embryotoxic, teratogenic, and metabolic effects of ribavirin in mice Toxicol Appl Pharmacol 52 1980 99 112
15. K.B. Schwarz, R.P. Gonzalez-Peralta, and K.F. Murray A randomized trial of peginterferon with or without ribavirin for chronic hepatitis C in children and adolescents Gastroenterology 140 2011 450 458
16. Z.D. Goodman, H.R. Makhlouf, and L. Liu Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial Hepatology 47 2008 836 843
17. G.L. Davis, J.B. Wong, and J.G. McHutchison Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C Hepatology 38 2003 645 652
18. P. Ferenci, M.W. Fried, and M.L. Shiffman Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin J Hepatol 43 2005 425 433
19. F. Bortolotti, G. Verucchi, and C. Camma Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease Gastroenterology 134 2008 1900 1907
20. A. Delgado-Borrego, D. Healey, and B. Negre Influence of body mass index on outcome of pediatric chronic hepatitis c virus infection J Pediatr Gastroenterol Nutr 51 2010 191 197
21. A. Delgado-Borrego, L.J. Smith, and M.M. Jonas Underdiagnosing of pediatric hepatitis C: a health care crisis in the state of Florida Gastroenterology 138 2010 232A
22. H.F. Zhang, X.J. Yang, and S.S. Shu An open-label pilot study evaluating the efficacy and safety of peginterferon alfa-2a combined with ribavirin in children with chronic hepatitis C Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 19 2005 185 187
23. A. Kowala-Piaskowska, W. Sluzewski, and M. Figlerowicz Factors influencing early virologic response in children with chronic hepatitis C treated with pegylated interferon and ribavirin Hepatol Res 32 2005 224 226
24. K.B. Schwarz, P. Mohan, and Markewicz Safety, efficacy and pharmacokinetics of peginterferon alpha2a (40 kd) in children with chronic hepatitis C J Pediatr Gastroenterol Nutr 43 2006 499 505
25. A. Kowala-Piaskowska, W. Sluzewski, and M. Figerlowicz Early virological response in children with chronic hepatitis C treated with pegylated interferon and ribavirin Infection 35 2007 175 179
26. P. Jara, L. Hierro, and A. de la Vega Efficacy and safety of pegylated interferon-alpha2b and ribavirin combination therapy in children with chronic hepatitis C infection Pediatr Infect Dis 27 2008 142 148
27. H. Tajiri, A. Inui, and Y. Kiyohara Peginterferon alpha-2b and ribavirin for the treatment of chronic hepatitis C in Japanese pediatric and young adult patients: a survey of the Japan Society of Pediatric Hepatology Eur J Gastroenterol Hepatol 21 2009 1256 1260
28. S. Wirth, C. Ribes-Kininckx, and M.A. Calzado High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin J Hepatol 52 2010 501 507
29. E.M. Sokal, A. Bourgois, and X. Stephenne Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in children and adolescents J Hepatol 52 2010 527 831
30. J. Al Ali, S. Owayed, and W. Al-Qabandi Pegylated interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4 in adolescents Ann Hepatol 9 2010 156 160